10-KPeriod: FY2008

INTUITIVE SURGICAL INC Annual Report, Year Ended Dec 31, 2008

Filed February 6, 2009For Securities:ISRG

Summary

Intuitive Surgical Inc. (ISRG) presented a strong financial performance in its 2008 10-K filing, showcasing significant revenue growth driven by the increasing adoption of its da Vinci Surgical System. The company reported a 46% increase in total revenue, reaching $874.9 million, with recurring revenue from instruments and accessories, and services, contributing 48% of the total. The installed base of da Vinci Surgical Systems grew to 1,111 units, facilitating approximately 136,000 procedures globally, with prostatectomies and hysterectomies being the dominant procedures. Despite a slowdown in system sales in the fourth quarter of 2008 due to the economic environment, the company maintained a healthy gross profit margin of 71% and a robust operating income of $310.8 million. ISRG's financial position remained strong with $901.9 million in cash, cash equivalents, and investments. The company continues to invest heavily in research and development, indicating a commitment to innovation and maintaining market leadership in robotic-assisted surgery.

Financial Highlights

46 data points
Beta

Revenue

$874.90M

71.0% Gross Margin

Net Income

$204.30M

23.4% Net Margin

EPS (Diluted)

$0.57

Total Assets

$1.47B

Cash & Equivalents

$194.60M

Free Cash Flow

$278.20M

Financial Statements
Beta
Revenue$874.90M
Cost of Revenue$254.10M
Gross Profit$620.80M
R&D Expenses$79.40M
SG&A Expenses$230.60M
Operating Expenses$310.00M
Operating Income$310.80M
Net Income$204.30M
EPS (Basic)$0.58
EPS (Diluted)$0.57
Shares Outstanding (Basic)350.10M
Shares Outstanding (Diluted)359.10M

Key Highlights

  • 1Total revenue grew 46% to $874.9 million in 2008, driven by strong adoption of the da Vinci Surgical System.
  • 2Recurring revenue (instruments, accessories, services) increased 52% to $419.6 million, representing 48% of total revenue.
  • 3Sold 335 da Vinci Surgical Systems in 2008, increasing the installed base to 1,111 systems.
  • 4Performed approximately 136,000 surgical procedures globally in 2008, with prostatectomies (73,000) and hysterectomies (34,000) being the most common.
  • 5Maintained strong gross profit margin of 71% and operating income of $310.8 million (36% of revenue).
  • 6Ended the year with a substantial cash, cash equivalents, and investments balance of $901.9 million.
  • 7Significantly increased R&D expenses by 62% to $79.4 million, reflecting investment in future product development and acquired intellectual property.

Frequently Asked Questions

Intuitive Surgical designs, manufactures, and markets the da Vinci Surgical System, an advanced robotic-assisted surgical system that enables surgeons to perform minimally invasive procedures with enhanced control, visualization, and dexterity.

The primary financial drivers were the significant increase in sales of da Vinci Surgical Systems, the growing utilization of these systems leading to higher recurring revenue from instruments and accessories, and the expansion of service contracts. The company also saw strong growth in the number of procedures performed using its systems.

Intuitive Surgical's strategy is to establish da Vinci surgery as the standard approach for complex surgical procedures, aiming to displace traditional open surgery and standard minimally invasive surgery. Key elements include focusing on key procedures and institutions, leveraging leading surgeons for adoption, maintaining market leadership through technological enhancement, developing industry alliances, and increasing patient awareness.

Key risks include achieving market acceptance for da Vinci surgery, the impact of economic conditions on customer spending, intense competition, long and variable sales cycles, manufacturing challenges, reliance on sole-sourced suppliers, regulatory hurdles, potential product liability claims, and the inability to protect intellectual property.